Navigation Links
DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
Date:12/19/2007

LA JOLLA, Calif., Dec 19 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, announced that it has been issued Patent No. 7,297,480 by the United States Patent and Trademark Office. The patent, entitled: "Method for Detection of Melanoma", includes claims focused on non-invasive methods for detecting early-stage melanoma and for staging, and claims for monitoring melanoma in a subject.

The patent claims the use of DermTech's "tape stripping" technology for the purposes of detecting, staging and monitoring melanoma. The methods claimed in the patent focus on the use of DermTech's EGIR (Epidermal Genetic Information Retrieval, a skin sampling technique known as "tape stripping" in combination with a molecular diagnostic assay). Specifically, adhesive tape is placed over a lesion suspicious for melanoma and then removed to harvest the top layer of skin cells. The RNA is extracted and analyzed to determine and compare the level of a key melanoma marker, Interleukin-2 Receptor 1 (IL-2 R1), with the level in a normal skin control sample. A decrease in IL-2 R1 is indicative of early-stage melanoma. The patent also claims the use of evaluating additional biomarkers based upon differences in gene expression such that a change in these messenger RNAs is indicative of late-stage melanoma. The ability to detect, stage and monitor disease is critical for improved clinical outcomes.

"DermTech welcomes the issuance of this patent as it will allow us to move forward and more fully develop and position our core EGIR technology for the staging as well as the detection, of melanoma," said George Schwartz, CEO, DermTech. "This patent is an important addition to our intellectual property portfolio."

The incidence rate of malignant melanoma is increasing faster than any other cancer. Treatment involves surgical excision of the primary lesion, and vigilant monitoring to detect recurrence. The methods for detecting malignant melanoma described in DermTech's newly issued patent can serve as the basis for therapeutic decisions, saving many lives and reducing costs by avoiding unnecessary excisions and biopsies.

About DermTech:

Headquartered in La Jolla, California, DermTech International is focused on the development and validation of molecular tests using specimens derived from the skin. The company's proprietary Epidermal Genetic Information Retrieval (EGIR) technology is in clinical studies to evaluate its potential as a non-invasive diagnostic for melanoma and other major diseases. It is also being studied in the context of tracking treatment efficacy for a variety of dermatologic and other conditions, including the effects of drugs on skin at the molecular level in advance of observable clinical results. DermTech is actively pursuing research using EGIR and its applications in the areas of melanoma, prostate cancer and various skin disorders, such as psoriasis. For additional information, visit http://www.dermtech.com

Contacts:

DermTech

George Schwartz

858.450.4222

For DermTech

Jennifer Larson

415.409.2729

jlarson@labfive.com


'/>"/>
SOURCE DermTech, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. DermTech Appoints BioStatistical Pioneer, John Quackenbush, Ph.D., as a Member of the Companys Scientific Advisory Board
2. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
5. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
8. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
9. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
10. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
11. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... ... July 18, 2017 , ... Genedata, a leading provider of ... technology company, has implemented Genedata Biologics ™ to scale-up their bispecific antibody ... and Neurodegenerative Diseases. , The need to systematically evaluate large panels of ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope Foundation won ... first phase of the Allotrope Framework for commercial use. , The Bio-IT World ... “not only elevate the critical role of information technology in modern biomedical research, ...
(Date:7/17/2017)... (PRWEB) , ... July 17, 2017 , ... The Academy ... local celebration of National Model Aviation Day will take place from 9 a.m. to ... and will include activities for all ages. , Aviation Adventure Day will be packed ...
(Date:7/17/2017)... ... 17, 2017 , ... Neurodevelopmental disorders (NDDs) are clinically and ... features. The advancement of targeted next-generation sequencing (NGS) has been instrumental in accelerating ... , However, designing a custom panel for disease research requires hours of up-front ...
Breaking Biology Technology:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):